Resective Surgery versus Debridement in Stage 2 Medication-Related Osteonecrosis of the Jaw

Resective Surgery versus Debridement in Stage 2 Medication-Related Osteonecrosis of the Jaw

The aim of this study is to analyze surgical and functional outcomes in order to verify the applicability of surgical treatment guidelines as foreseen by MASCC/ISOO/ASCO 2019. Patients affected by stage 2 MRONJ refractory to conservative management were grouped if underwent surgical resection (Group...

Full description

Bibliographic Details
Main Authors:	Salvatore D’Amato, Antonio Troiano, Giorgio Lo Giudice, Davide De Cicco, Mario Rusciano, Gianpaolo Tartaro, Giuseppe Colella
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	Applied Sciences
Subjects:	MRONJ medication-related osteonecrosis of the jaw BRONJ debridement resective surgery
Online Access:	https://www.mdpi.com/2076-3417/11/18/8553

Similar Items

A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats
by: Suzanna L. Hatunen, et al.
Published: (2024-08-01)

Fat Graft in Surgical Treatment of Medication-Related Osteonecrosis of the Jaws (MRONJ)
by: Davide De Cicco, et al.
Published: (2021-11-01)

Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw
by: Winnie Zee Man Wat
Published: (2016-10-01)

Medication-Related Osteonecrosis of the Jaw—A Continuing Issue
by: Krzysztof Wróbel, et al.
Published: (2021-08-01)

Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition
by: Mario Migliario, et al.
Published: (2017-03-01)

Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
by: Falk Wehrhan, et al.
Published: (2019-03-01)

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw
by: Zuzana Janovska, et al.
Published: (2015-06-01)

The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
by: Christian Bacci, et al.
Published: (2021-01-01)

Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures
by: Gioacchino Catania, et al.
Published: (2016-12-01)

Medication-related osteonecrosis of the jaw treatment modalities: A review
by: Amir Ali Asadi
Published: (2020-08-01)

Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series
by: Filipa Frutuoso, et al.
Published: (2024-09-01)

BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW AND DENTAL IMPLANTS
by: Ala Hassan A. Qamheya, et al.
Published: (2016-01-01)

Case Report: Development of medication-related osteonecrosis of the jaw in a patient on long-term infliximab therapy
by: Derek Oryniak, et al.
Published: (2024-07-01)

Clinical diagnosis and treatment on bisphosphonate⁃related osteonecrosis of the jaw
by: YIN Xue⁃min, et al.
Published: (2017-03-01)

Osteonecrosis of the jaw after dental implant placement. A case report
by: J.L. Calvo-Guirado, et al.
Published: (2014-03-01)

Oral Complications in Cancer Patients–Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Cesar Augusto Migliorati
Published: (2022-04-01)

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
by: Saad Hajeri, BDS, et al.
Published: (2022-09-01)

Medication‐related osteonecrosis of the jaw and successful implant treatment in a patient on high‐dose antiresorptive medication: A case report
by: Camilla Ottesen, et al.
Published: (2022-10-01)

Autologous Platelet-Rich Fibrin (PRF) as an Adjunct in the Management of Osteoradionecrosis and Medication-Related Osteonecrosis of Jaws. Case Series in A Single Centre
by: Benjie Law, et al.
Published: (2021-04-01)

Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
by: Pan WL, et al.
Published: (2017-07-01)

Treatment of Biphosphonate-Related Osteonecrosis of the Jaw (BRONJ) Combining Surgical Resection and PRGF-Endoret® and Rehabilitation with Dental Implants: Case Report
by: Anitua Eduardo
Published: (2017-03-01)

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
by: Vittorio Fusco, et al.
Published: (2018-09-01)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Sven Otto, et al.
Published: (2021-05-01)

Bisphosphonate therapy and osteonecrosis of the jaw complicated with a temporal abscess in an elderly woman with rheumatoid arthritis: a case report
by: Manzon L, et al.
Published: (2014-08-01)

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology
by: Aya Alsalih, et al.
Published: (2021-07-01)

Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases
by: Francesco Erovigni, et al.
Published: (2016-10-01)

Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents
by: Lukas Hauer, et al.
Published: (2020-03-01)

Medication-Related Osteonecrosis of the Jaw in Dental Practice: A Retrospective Analysis of Data from the Milan Cohort
by: Cristina Mirelli, et al.
Published: (2022-05-01)

MicroRNA in medication related osteonecrosis of the jaw: a review
by: Siti Salmiah Mohd Yunus, et al.
Published: (2023-04-01)

Awareness and practice of dentists in gulf cooperation council countries regarding medication-related osteonecrosis of the jaw – A web-based survey
by: Mohammad Zakaria Nassani, et al.
Published: (2023-10-01)

Bone resection methods in medication-related osteonecrosis of the jaw in the mandible: An investigation of 206 patients undergoing surgical treatment
by: Koki Suyama, et al.
Published: (2024-07-01)

Treatment of medication-related osteonecrosis of the jaw with cell therapy
by: Cyril Lucien Bouland, et al.
Published: (2024-01-01)

The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma
by: Shin-Yu Lu, et al.
Published: (2021-11-01)

Awareness, perceptions and attitudes toward medication-related osteonecrosis of the jaw among physicians who treat osteoporosis
by: Suad Aljohani
Published: (2023-09-01)

Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy
by: Abdulrhman Al Abdullateef, et al.
Published: (2020-06-01)

Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw
by: Jeong Won Shin, et al.
Published: (2024-04-01)

Plasma Therapy for Medication-Related Osteonecrosis of the Jaws- A Case Report
by: Maryam Jalili Sadrabad, et al.
Published: (2023-07-01)

A Systematic Review of Laser Photobiomodulation Dosimetry and Treatment Protocols in the Management of Medications-Related Osteonecrosis of the Jaws: A Rationalised Consensus for Future Randomised Controlled Clinical Trials
by: Reem Hanna, et al.
Published: (2024-07-01)

Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid
by: Ling-Ying Wei, et al.
Published: (2021-08-01)

Oral Squamous Cell Carcinoma Mimicking Medication-Related Osteonecrosis of the Jaws (MRONJ): A Case Series
by: Rodolfo Mauceri, et al.
Published: (2021-11-01)